Dr. Eva Feldman
Throughout her career, Dr. Eva Feldman has made it her mission to use scientific discoveries to understand and cure human diseases. As the Russell N. DeJong, Professor of Neurology at the University of Michigan, she has made important contributions to medical research and clinical care in many critical areas, including Amyotrophic Lateral Sclerosis (ALS) and complications in Diabetes. She developed a clinical screening instrument for the rapid diagnosis of diabetic neuropathy, which is currently being used worldwide.
In January 2008, Dr. Feldman was named the first Director of the A. Alfred Taubman Medical Research Institute, which was created to support fundamental research into a wide range of human diseases. Under her leadership, the Taubman Institute funds senior-level scientists in a diverse spectrum of diseases – adult and childhood cancer, ALS, diabetes, cardiovascular disease and hearing loss.
In the fall of 2008, Dr. Feldman and the Taubman Institute played a leadership role in educating Michigan citizens on the importance of stem cell research in the study and treatment of disease. In the November election, voters approved a constitutional amendment lifting restrictions on stem cell research in the state. The Taubman Institute is working to make the University of Michigan one of the nation’s leaders in this emerging technology. In her own work, Dr. Feldman is on of the forefront of applying stem cell research to human disease. In September, she received approval from the F.D.A. for the first human clinical trial of a stem cell cure for ALS.
Facts about Eva L. Feldman, M.D., Ph.D.:
- Russell N. DeJong Professor of Neurology
- Director, A. Alfred Taubman Medical Research Institute
- Director, JDRF Center for the Study of Complications in Diabetes
- Director, ALS Clinic
- Specialty: Neurology
- Research interests: Nerve regeneration, peripheral neuropathy, motor neuron disease
- M.D.: University of Michigan, 1983
- Ph.D.: University of Michigan, 1979